WASHINGTON — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported this week. “Finally there’s ...

New Alzheimer's drug raises hopes — along with questions. First there was aducanumab (sold as Aduhelm by Biogen), approved by the FDA in June 2021.

No cure exists, but medications and management strategies may temporarily improve the symptoms. The landscape shifted in 2021, when the FDA approved Aduhelm, the first Alzheimer’s drug showing ...

Eli Lilly’s stock price jumped 6.7% after it announced positive results from a trial of one new Alzheimer’s drug, increasing the company’s value by more than $25 billion that day.

European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.

UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...

The harmful clumps of tau protein that build up in brains affected by Alzheimer's were reduced significantly, and the mice ...

As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...

Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

The Food and Drug Administration on Monday approved a high-profile Alzheimer's drug, a controversial decision to green light the first new drug to slow the mind-robbing disease in nearly two decades.